Iterium

Rilmenidine, the active ingredient in Iterium, is an imidazoline receptor agonist presented as a tablet for oral use. It lowers elevated blood pressure in adults with essential hypertension and is approved for prescription use within the European Union.

GNH USA supplies Iterium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets and adhering to stringent quality standards with global logistics support.

Iterium (rilmenidine) is employed in the management of hypertension, a condition characterized by chronically elevated arterial pressure. - Essential hypertension: reduces systolic and diastolic blood pressure in patients with primary hypertension. - Hypertension as part of combination therapy: added to other antihypertensive agents when monotherapy does not achieve target pressure. - Resistant hypertension: may be considered as an adjunct in patients whose blood pressure remains uncontrolled despite multiple agents.

Rilmenidine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially upon standing. - Dry mouth: reduced salivation causing throat discomfort. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate pain in the head.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that may cause fainting. - Liver enzyme elevation: increase in ALT or AST indicating possible hepatic stress. - Allergic reactions: rash, itching, swelling, or angioedema requiring medical attention.

Before initiating therapy, clinicians should consider several safety measures. - Monitor blood pressure: check regularly to assess therapeutic response. - Avoid abrupt discontinuation: taper under medical supervision to prevent rebound hypertension. - Use caution in renal impairment: adjust therapy if kidney function is reduced. - Use caution in hepatic impairment: monitor liver function tests during treatment. - Avoid concomitant use with MAO inhibitors: increased risk of hypotensive episodes. - Store at room temperature: keep in original container, protect from moisture and light.

Rilmenidine can interact with other medicines, requiring attention to the level of risk.

Major Interactions (Avoid): - MAO inhibitors: combined use may cause excessive hypotension. - Other central antihypertensives (e.g., clonidine): additive blood‑pressure‑lowering effect.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive effect. - Diuretics: can enhance hypotensive response. - Lithium: possible increase in lithium levels; monitor serum concentrations.